Related Experiment Video
Updated: May 22, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
Urinary tract infection caused by carbapenem-resistant K. pneumoniae and P. aeruginosa
Ioana D Olaru1, Mona Popoiu, J Breuil
1Prof. Dr. Matei Balş National Institute of Infectious Diseases, Bucharest, Romania. ioanad_olaru@yahoo.co.uk
Abstract:
There has been an increase in recent years of antimicrobial resistance of Gram negative bacilli (GNB). Carbapenems, the mainstay for the treatment of multidrug resistant GNB infections, are no longer always effective leaving treatment options limited. We present the case of patient with recurrent, complicated urinary tract infections. The current episode was caused by carbapenem-resistant K. pneumoniae and P. aeruginosa and carbapenem-susceptible, but MDR E. cloacae. Resistance to carbapenems of K. pneumoniae was conferred by the production of the class B metallo-beta-lactamase, VIM1. Infection control measures were implemented and following a 2-week course of treatment with colistin, the infection resolved and the patient was discharged. We discuss the changes in the epidemiology, the mechanisms involved and the means of detecting carbapenem resistance in GNB. We would also like to stress the role of infection control measures in limiting patient-to-patient spread of MDR organisms which, are of paramount importance in cases when few treatment options are left available.
Insights
Antimicrobial resistance in Gram-negative bacilli (GNB) is rising, limiting treatment options. A case study highlights colistin
Area of Science:
- Medical microbiology
- Infectious diseases
- Antimicrobial resistance
Background:
- Rising antimicrobial resistance in Gram-negative bacilli (GNB) poses a significant global health threat.
- Carbapenems, crucial for treating multidrug-resistant GNB infections, are becoming less effective.
- Limited treatment alternatives necessitate understanding resistance mechanisms and effective management strategies.
Observation:
- A patient presented with recurrent, complicated urinary tract infections.
- Infections involved carbapenem-resistant Klebsiella pneumoniae and Pseudomonas aeruginosa, alongside carbapenem-susceptible but multidrug-resistant Enterobacter cloacae.
- Klebsiella pneumoniae exhibited carbapenem resistance due to VIM1 metallo-beta-lactamase production.
Findings:
- A 2-week course of colistin effectively treated the carbapenem-resistant Klebsiella pneumoniae and Pseudomonas aeruginosa infections.
- The patient's infection resolved, leading to successful discharge.
- Implementation of infection control measures was crucial in managing the multidrug-resistant organisms.
Implications:
- Highlights the increasing challenge of carbapenem resistance in Gram-negative bacilli.
- Emphasizes colistin as a viable treatment option for carbapenem-resistant Gram-negative infections.
- Stresses the critical role of infection control in preventing the spread of multidrug-resistant organisms and preserving limited therapeutic options.
Related Concept Videos
Urinary Tract Infection II: Pathophysiology
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Urinary Tract Infection I: Introduction
Acute Pyelonephritis I: Introduction
Atypical Pneumonia

